Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis)
This study has been terminated.
( 12/15/2008 Voluntarily placed on inactive status-requested by the PI )
Study NCT00590538 Information provided by Children's Hospital of Philadelphia
First Received: December 27, 2007 Last Updated: February 2, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cystic Fibrosis
Additional conditions recognized in this trial
Fibrosis
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Sodium 4-Phenylbutyrate
Unconjugated Isoflavones 100
Placebo
Additional drug interventions recognized in this trial
4-phenylbutyric acid
Genistein
More general drug interventions related to this trial
Anticarcinogenic Agents
Antineoplastic Agents
Enzyme Inhibitors
Estrogens
Estrogens, Non-Steroidal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Phytoestrogens
Protective Agents
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Children's Hospital of Philadelphia
Cystic Fibrosis Foundation
Back to top of Main Content
